PSIVANT
"PSIVANT" is a word mark owned by Psivant Therapeutics, Inc., filed at the USPTO on February 1, 2023. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since December 3, 2024
- Filed
- February 1, 2023
- Registered
- December 3, 2024
- Priority date
- August 22, 2022
- Claimed from Switzerland
- Application no.
- 97776585
- Registration no.
- 7583609
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns PSIVANT
The owner and representative on file with the office.
Owner
Psivant Therapeutics, Inc.
Boston, United States
Representative
Joyce M. Ferraro
Fross Zelnick Lehrman & Zissu, P.C.
What the mark covers
The products and services PSIVANT is filed for, grouped by Nice class.
Pharmaceutical preparations for human use for use in the fields of oncology, inflammation, and immunology; biologic preparations for medical and therapeutic purposes for use in the fields of oncology, inflammation, and immunology
Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; analysis of technical data by computers, being technical medical research in the field of healthcare, prescription and related data being carried out using computers; pharmaceutical, biomedical, biological therapeutic research services; pharmaceutical, biomedical, biological therapeutic research services using molecular dynamics simulation to improve upon existing drugs with known deficiencies; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for use in database management; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, medical information, clinical trial and post-market trial data for collecting, analyzing and organizing data; providing temporary use of online nondownloadable computer software for management of medical practices and research; providing temporary use of online nondownloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; providing temporary use of online non-downloadable computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services
Providing health and medical information; providing internet-based healthcare information; providing medical and healthcare information to healthcare professionals regarding patient data; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; medical services; medical and pharmaceutical consultation; medical services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, mobile and wireless devices, and other telecommunication devices; medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Post publication amendment - entered
- Assigned to petition staff
- Teas post publication amendment received
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
10 earlier steps on the official record.
About PSIVANT
Who owns the trademark "PSIVANT"?
The USPTO trademark "PSIVANT" (application 97776585) is owned by Psivant Therapeutics, Inc.
What is the status of "PSIVANT"?
Its status at the USPTO is: registered.
When was "PSIVANT" registered?
It was registered on December 3, 2024.
Get this data via the API
Everything on this page comes from the Signa API. Pull PSIVANT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b56-4288-726d-8ead-d454d1d4e042
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b56-4288-726d-8ead-d454d1d4e042",
"object": "trademark",
"mark_text": "PSIVANT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97776585",
"filing_date": "2023-02-01",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "PSIVANT THERAPEUTICS, INC.",
"entity_id": null
}
]
}